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The human high affinity receptor for IgE (Fc
 
 
 
RI) is a cell surface structure critical for the 
pathology of allergic reactions. Human Fc
 
 
 
RI is expressed as a tetramer (
 
   
 
2
 
) on basophils 
or mast cells and as trimeric (
 
  
 
2
 
) complex on antigen-presenting cells. Expression of the 
human 
 
 
 
 subunit can be down-regulated by a splice variant of Fc
 
 
 
RI
 
 
 
 (
 
 
 
var
 
). We 
demonstrate that Fc
 
 
 
RI
 
 
 
 is the core subunit with which the other subunits assemble strictly 
cotranslationally. In addition to 
 
   
 
2
 
 and 
 
  
 
2
 
, we demonstrate the presence of 
 
  
 
 and 
 
  
 
var
 
 
 
2
 
 complexes that are stable in the detergent Brij 96. The role of individual Fc
 
 
 
RI 
subunits for the formation of functional, immunoglobulin E–binding Fc
 
 
 
RI complexes during 
endoplasmic reticulum (ER) assembly can be defined as follows: 
 
 
 
 and 
 
 
 
 support ER 
insertion, signal peptide cleavage and proper N-glycosylation of 
 
 
 
, whereas 
 
 
 
var
 
 allows 
accumulation of 
 
 
 
 protein backbone. We show that assembly of Fc
 
 
 
RI in the ER is a key step 
for the regulation of surface expression of Fc
 
 
 
RI. The ER quality control system thus 
regulates the quantity of functional Fc
 
 
 
RI, which in turn controls onset and persistence of 
allergic reactions.
 
A significant fraction of the population (
 
 
 
20%)
in the Western world is affected by allergies and
the numbers of affected individuals is on the rise
(1, 2). Convincing evidence exists that Fc
 
 
 
RI is
one of the key molecules in the pathophysiology
of all allergic reactions (3–6). As a member of the
antigen receptor superfamily, Fc
 
 
 
RI shares the
organizational principles of a ligand binding
immunoglobulin-type protein associated with
signaling subunits that regulate cellular activation
via conserved immunoreceptor tyrosine–based
signaling motifs (ITAMS; 7). BCR, TCR, and
other Fc receptors fall in the same class (7–10).
Fc
 
 
 
RI was initially described as a tetrameric
receptor composed of a high-affinity ligand-
binding 
 
 
 
 chain, one 
 
 
 
 chain, and a pair of
disulphide-linked 
 
 
 
 subunits (5, 9). The Fc
 
 
 
RI
complexes on the surface of basophils and mast
cells are tetrameric structures (
 
   
 
2
 
). The 
 
   
 
2
 
is the only receptor isoform formed in rodents
(5). Human antigen-presenting cells additionally
display a trimeric form of Fc
 
 
 
RI that lacks the
 
 
 
 subunit (5, 11, 12). A new splice variant of
Fc
 
 
 
RI
 
 
 
 (
 
 
 
var
 
, formerly referred to as 
 
 
 
T
 
) exerts a
dominant negative effect on 
 
 
 
 function (13).
The structural integrity of Fc
 
 
 
RI is main-
tained by the noncovalent interactions of its
various subunits. The extracellular domain of
Fc
 
 
 
RI
 
 
 
 forms the binding site for the C
 
H
 
3
domain of IgE. It binds its ligand in 1:1 ratio,
with an affinity of 
 
 
 
10
 
10
 
 M
 
 
 
1
 
. The 
 
 
 
 chain
contains four potential transmembrane spanning
regions with both the NH
 
2
 
 and the COOH
terminus protruding into the cytosol. Fc
 
 
 
RI
 
 
 
forms a dimer and is a member of the 
 
 
 
 gene
family. IgE-dependent cross-linking of Fc
 
 
 
RI
induces cellular activation regulated via ITAMs,
which are present in one copy in the 
 
  
 
as well
as in each of the 
 
 
 
 chains (5, 9, 10). The 
 
 
 
subunit, when expressed in the absence of 
 
 
 
and 
 
 
 
, is retained in the ER. The ER reten-
tion signal of human 
 
 
 
 can be overcome by
the presence of 
 
 
 
 alone. Fc
 
 
 
RI
 
 
 
 was defined
as an amplifier for 
 
 
 
 chain signaling in vitro
and in vivo (14, 15) and as a regulator for sur-
face expression. The 
 
 
 
var
 
 subunit is a splice
variant that has lost its ITAM (13). Therefore
 
 
 
var
 
-containing complexes must behave signif-
icantly differently from those that contain the
conventional 
 
 
 
 chain.
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Multisubunit receptor complexes, like Fc
 
 
 
RI or the TCR,
are assembled in the ER, from where they enter the secretory
pathway (16, 17). The acquisition of the proper tertiary and
quaternary structure in the ER is a carefully controlled se-
quence of events. Nascent polypeptides are subject to modifica-
tions, which often include signal–peptide cleavage, N-linked
glycosylation and oligosaccharide trimming. Folding of proteins
is guided by chaperones such as BiP and the lectins calnexin
and calreticulin. Oxido-reductases control the formation of di-
sulfide bonds between the correct pairs of cysteine residues to
stabilize the folded structure (18). As a consequence of imper-
fections in protein folding, some polypeptides never attain their
native conformation. Terminally misfolded proteins are singled
out in the ER by a quality control process (19–21). However,
their destruction takes place mostly in the cytosol. ER quality
control substrates may cross the ER membrane before their
degradation (22). In addition to the proper folding of the indi-
vidual subunits, multimeric receptors like Fc
 
 
 
RI must assemble
in a concerted fashion. Only with all players in place, can ER
retention signals be overcome. The sequence of events in
Fc
 
 
 
RI receptor assembly in its various configurations is inter-
esting with respect to the functional differences of the receptor
isoforms. These events all contribute to the control of receptor
expression and thereby the outcome of allergic responses in
vivo. The generally increased cell surface expression of Fc
 
 
 
RI
in allergic individuals supports this hypothesis (23, 24).
Studies on the human receptor are hampered by a lack of
cell lines that express Fc
 
 
 
RI irrespective of its isoforms. Pri-
mary human cells that express Fc
 
 
 
RI are difficult to obtain,
even in small numbers. Because these cells shut down synthe-
sis of the receptor immediately after isolation, they cannot be
used to study complex formation and regulation of surface
expression. We therefore used in vitro translation in mem-
brane-supplemented rabbit reticulocyte lysates to study the
early events of Fc
 
 
 
RI assembly in the ER. We translated the
corresponding mRNAs of all Fc
 
 
 
RI subunits and performed
studies on temporal aspects of protein–protein interaction and
their consequences for receptor assembly. Our results show
that ER assembly of the individual Fc
 
 
 
RI subunits is tightly
controlled and indeed regulates the formation of properly
formed receptors with IgE-binding epitopes.
 
RESULTS
In vitro translation of Fc
 
 
 
RI
 
 
 
We used in vitro translation as a method to study Fc
 
 
 
RI re-
ceptor assembly in the ER (16, 25, 26), because aspects of
multimeric receptor assembly cannot be studied in a time-
resolved fashion in transfection experiments. First, we char-
acterized the properties of the individual receptor subunits in
this assembly system. The cDNAs for the human Fc
 
 
 
RI sub-
units allow the generation of the corresponding mRNAs for
in vitro translations. The mRNAs were translated in the
presence of microsomes from different sources. Fc
 
 
 
RI
 
 
 
 is a
type I membrane protein and requires cleavage of its signal
sequence before N-glycosylation, which is in turn required
for the formation of functional IgE-binding sites (5, 9).
Fc
 
 
 
RI
 
 
 
 cDNA equipped with its endogenous signal peptide
translated poorly. Although we could detect the expected
polypeptides reactive with anti–
 
 
 
 serum, cotranslation of the
 
 
 
 construct with 
 
 
 
 and 
 
 
 
 mRNAs would have rendered fur-
ther assembly studies technically difficult (unpublished data).
We therefore exchanged the signal sequence of the 
 
 
 
 sub-
unit for that of H2-K
 
b
 
. The latter has proved efficient for
translation as well as for adjustment of insertion efficiencies
of different subunits during TCR assembly (16). This swap
of signal peptides allowed efficient translation of Fc
 
 
 
RI
 
 
 
(H2-KbFc RI , referred to as  ; Fig. 1 A). The source of
microsomes proved critical for the generation of   chains
with cleaved signal peptide (  sig, Fig. 1 A) as well as for
N-glycosylation ( Nglyc, Fig. 1 A), although no such effect was
observed for Fc RI  or HLA-2A (unpublished data). Mi-
crosomes from the basophilic cell line KU812 allowed effi-
Figure 1. In vitro translation of IgE-binding Fc RI . (A) Signal peptide 
cleavage and N-glycosylation of Fc RI  depends on the source of microsomes 
used during in vitro translation. Transcripts of Kb-Fc RI  were translated 
for 1 h at 30 C in the presence of microsomes derived from KU812, dog 
pancreas (dpm), or U373 (CC). After lysis of the microsomal pellets in 1% 
Brij96 lysis buffer, immunoprecipitates were obtained with polyclonal anti-  
serum and either mock digested or digested with Endo H. Subsequently 
immunoprecipitates were analyzed by 12.5% SDS-PAGE under reducing 
conditions. Conversion of   sig to  Nglyc occurs most efficiently in CC mi-
crosomes. (B)  Nglyc generated with CC microsomes expresses properly folded 
IgE-binding epitopes. IgE selectively precipitates the fully N-glycosylated form 
of Fc RI . Representative experiments (n   3).JEM VOL. 201, January 17, 2005 269
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cient translation, but yielded   mostly as   sig (Fig. 1 A).
Microsomes derived from canine pancreas were successful in
creating  Nglyc, but a sizable fraction of the translated protein
was present as   sig (Fig. 1 A and unpublished data). Mi-
crosomes derived from the astrocytoma cell line U373 (CC)
reproducibly generated endoglycosidase H (EndoH)-sensi-
tive  Nglyc efficiently (Fig. 1 A).
We then asked whether we could generate Fc RI  with
proper IgE-binding epitopes, using IgE as the bait to recover
translation products from microsomal pellets (Fig. 1 B). The
direct analysis of the microsomal extracts shows the presence
of all forms of Fc RI  (  sig,   sig, and  Nglyc, Fig. 1 B), but
only properly folded and N-glycosylated   is recovered by
IgE (Fig. 1 B).
In vitro translation of Fc RI  and Fc RI var
The identity of the translation products from   and  var (13)
was confirmed by immunoprecipitation with an anti-  se-
rum generated against the NH2 terminus of  , therefore re-
active with both splice variants (Fig. 2 A). Indeed, both pro-
teins migrate at their expected molecular weight of  28,000
and 22,000, respectively (Fig. 2 A; reference 13).
In vitro translation of Fc RI 
The    chain is a type I membrane protein (3, 8, 9). To
achieve comparable translation efficiencies, we exchanged the
signal sequence of   that of H2-Kb (H2-KbFc RI , referred
to as  ; Fig. 3). Fig. 3 A shows the proper insertion and signal
peptide cleavage of   in the in vitro translation assay with a
[35S]cysteine translation mix. The single methionine present in
  is removed upon insertion into the microsomes. However,
labeling with the [35S]methionine translation mix (containing
both [35S]Met and [35S]Cys) allows sufficient labeling as shown
in anti-  immunoprecipitations (Fig. 3 B). For reasons that re-
main unclear, in vitro translations using [35S]cysteine did not
allow visualization of  var (unpublished data). Thus, all subse-
quent translation assays were performed with the [35S]methio-
nine translation mix. Under nonreducing conditions,   runs as
a dimer with both translation mixes (Fig. 3, C and D).
Receptor assembly studies:    complexes form 
cotranslationally
The next set of experiments addressed the existence of   
complexes and their assembly. Anti-  immunoprecipitations
from Brij 96 lysates of microsomal pellets demonstrate the
Figure 2. In vitro translation of Fc RI  and Fc RI var. (A) Transcripts 
of Fc RI  or Fc RI var were translated for 1 h at 30 C in the presence of 
CC microsomes. After lysis of the microsomal pellets in 1% Brij96 lysis 
buffer, immunoprecipitates were obtained with polyclonal anti-  serum 
and analyzed by 12.5% SDS-PAGE under reducing conditions. Representa-
tive experiments (n   3).
Figure 3. ER insertion and proper signal peptide cleavage of Fc RI . 
(A) Proper insertion and signal peptide cleavage of Kb-  in an in vitro transla-
tions with a [35S]cysteine translation mix. (B) In vitro translations of Kb-  with 
a [35S]methionine translation mix. The single methionine of   gets cleaved 
after insertion into the microsomes. [35S]Cysteine present in the [35S]methio-
nine translation mix is sufficient for labeling of Kb- . In vitro translations 
were performed in the absence and presence of CC microsomes. Translation 
products were analyzed after immunoprecipitation from 1% Brij96 lysates of 
in vitro translations performed in the absence of microsomes ( ) or lysates 
of microsomal pellets ( ) and analyzed by 12.5% SDS-PAGE under reducing 
(A and B) or nonreducing (C and D) conditions. Fc RI  forms a dimer under 
nonreducing conditions. Representative experiments (n   3).RECEPTOR SUBUNITS CONTROL EFFICIENCY OF FC RI ASSEMBLY | Fiebiger et al. 270
presence of stable    complexes (Fig. 4 A, lane 4). Such
complexes arise only if both proteins are translated at the
same time. Microsomal pellets from assay mixtures in which
  and   RNA were translated consecutively are devoid of   
complexes, despite the presence of both proteins in the direct
load of the microsomes (Fig. 4 A, lanes 1 and 3). Complexes
of    where absent when proteins were translated separately
and then mixed before or after lysis (Fig. 4 B; and unpub-
lished data). Direct loads of microsomes from translation mix-
tures in which   and   were present concurrently generally
show more properly folded  Nglyc when compared with sam-
ples in which   was translated alone. This effect is even more
pronounced when   is cotranslated as well (unpublished data
and see Fig. 6 A). Immunoprecipitations of    complexes
with serum directed against   confirmed the association of
  sig,   sig, and  Nglyc with   (Fig. 4 C).
Cotranslation of   and   chains resulted in efficient in-
sertion of both proteins into microsomes (Fig. 5 A, lane 1).
Neither serum coprecipitated the other protein. These ex-
periments control for proper solubilization under the neces-
sary mild lysis conditions and further show that    com-
plexes do not occur in the absence of   (Fig. 5 A, lanes 2 and
3). We also failed to detect    complexes when   and  
mRNAs were translated separately and microsomes were
mixed before lysis (Fig. 5 D and E, lanes 2) or when mi-
crosomal pellets of cotranslation experiments were lysed in
1% digitonin (unpublished data).
These results fit with the assumption that the   chain is
the core of all Fc RI complexes. This hypothesis also im-
plies a direct interaction of   with  . We therefore at-
tempted to demonstrate the existence of such complexes by
in vitro translation. As shown in Fig. 5 B, the    complex is
stable in Brij96 and is generated only cotranslationally (Fig.
5, D and E, lanes 3). Due to its molecular weight,   is diffi-
cult to distinguish from   sig and   sig. The anti-  reimmu-
noprecipitation unequivocally demonstrates the existance of
   complexes (Fig. 5 B, lane 2). We could also demonstrate
the presence of these complexes on a cellular level by immu-
noprecipitations from 293 cells transiently transfected with  
and   complexes (Fig. 5 C). The use of tagged versions of
both proteins allowed the detection of the individual sub-
units by immunoblotting after immunoprecipitation. The
   complexes can be retrieved specifically with an anti-HA
reagent via  HA (Fig. 5 C, lanes 2–4), but not with a control
Ab (Fig. 5 C, lane 1). A considerable amount of this   pro-
tein becomes EndoH resistant, indicative of modifications of
N-glycans in the Golgi apparatus ( mod; Fig. 5 C, lane 3) and
thus proper ER exit of    complexes. Digestion of immu-
nopreciptated    complexes with PNGase was performed to
provide further evidence for proper folding of  . PNGase
preferentially attacks improperly folded glycoproteins (27),
and the resistance of   to digestion by this enzyme thus sup-
ports our findings that   is expressed as properly folded pro-
tein in    complexes.
Cotranslation of HLA-A2 with   and   were performed
as specificity controls (Fig. 5 D, lanes 4 and 6). As expected,
HLA-A2 failed to form a complex with   and   (Fig. 5 E,
lanes 4 and 6).
Immunoprecipitation of     and   var  complexes
The  , ,  , or  , var,   mRNAs were translated into mi-
crosomes, which were then solibilized in 1% Brij96 and
subjected to immunoprecipitation. The anti-  but not the
control serum successfully precipitated     complexes (Fig.
6 A). The anti-  reagent also retrieved stable   var 
complexes (Fig. 6 A). The   chain in the latter complexes
seemed to be underrepresented when compared with    .
Figure 4. Fc RI complexes form cotranslationally. (A) Cotranslational 
formation of    complexes.   and   RNA were translated consecutively 
(lanes 1 and 3, 1st  2nd ) or at the same time (lane 2 and 4,      ) into CC 
microsomes. Direct loads of the microsomal pellets confirmed the presence 
of both translation products (lanes 1 and 2).    complexes were only re-
trieved by anti-  immunopreciptiation, if both proteins were translated at 
the same time (lane 4,      ). (B)   and   were translated separately and 
microsomal pellets were mixed before lysis. Direct loads of microsomes 
showed the presence of both proteins. No    complexes were precipi-
tated. (C) Immunoprecipitations of    complexes with serum directed 
against  .JEM VOL. 201, January 17, 2005 271
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 var induces the accumulation of   sig
We next examined the fate of   when translated in the pres-
ence of  var. For this purpose   var  mRNAs were cotrans-
lated and direct loads of microsomal pellets were compared
with anti-  immunoprecipitates to assess more carefully all
forms of   present in the translation mix (Fig. 6 B). We de-
tected the presence of all translated proteins, with a prominent
band of  33 kD. Anti-  immunoprecipitation confirmed the
nature of this polypeptide as   sig (Fig. 6 B). The   chain as
well as  Nglyc and   sig were coprecipitated. For unknown rea-
sons, we were unable to directly demonstrate  var in these
precipitates. This finding might again reflect a decrease in the
stability of   var  complexes, with  var dissociating before  ,
or equally likely, a more general problem of detection of  var.
As in cellular expression systems (13),  var is rapidly lost from
in vitro translation mixtures (unpublished data).
 var down-regulates surface IgE-binding epitopes
We subcloned   and  var into a bicistronic vector with
EGFP (pIRES2- -EGFP and pIRES2- var-EGFP). Next,
293 cells were transiently transfected and treated with pro-
teasome inhibitor for 2h. After SDS lysis, immunoblots with
anti-  serum were performed to confirm the proper expres-
sion of both proteins (Fig. 7 A).
We verified that mAb 15–1 recognizes the IgE-binding
epitope of Fc RI  (13, 23, 28–30). IgE binding capacity of
CHO   was assessed by FACS with biotinylated IgE (Fig. 7
B, filled black). CHO   show comparable reactivity when
stained with 15–1 (Fig. 7 B, blue). Preincubation of cells
with 15–1 inhibits subsequent IgE binding (Fig. 7 B, red).
The   mean fluorescence intensity ( MFI) of IgE-reactivity
drops from 370 to levels of the negative control (Fig. 7 B,
black line,  MFI 10). This result is in accordance with the
literature (13, 23, 28–30) and confirms that 15–1 recognizes
the IgE-binding site of Fc RI . The fact that both reagents
recognize the same epitope also accounts for the misinter-
pretation of cellular distribution patterns of Fc RI  in hu-
mans. Endogenous IgE bound to Fc RI  precludes recogni-
tion with mAb 15–1 or biotinylated IgE unless the natural
ligand is removed by acid stripping (23, 28–30).
Figure 5. Association studies of different Fc RI subunits. (A) Cotransla-
tion of   and   chains results in efficient expression of both proteins in 
microsomes. Anti-  and -  serum both failed to coprecipitate    com-
plexes. (B) Demonstration of    complexes. Anti-  serum precipitates 
stable    complexes. The presence of   is in the complex is confirmed by 
anti-  reimmunoprecipitations. (C) Confirmation of    complexes in 293 
cells transiently transfected with  HA and GFP-  cDNA. (D and E) The   
and   subunits associate with   but not HLA-A2. Fc RI complexes form 
only cotranslationally. Direct loads of microsomes (D) in which proteins 
were translated separately and mix before lysis (lanes 1–3) and microsomes 
from cotranslations (lanes 4–6) were compared with immunoprecipitations. 
Complexes were precipitated from 1% Brij96 lysates of in vitro transla-
tions from CC pellets and analyzed by 12.5% SDS-PAGE under reducing 
conditions. Representative experiments (n   3).RECEPTOR SUBUNITS CONTROL EFFICIENCY OF FC RI ASSEMBLY | Fiebiger et al. 272
We show that our bicistronic constructs regulate the sur-
face expression of IgE-binding epitopes as previously de-
scribed (13). For this purpose, CHO    were transiently
transfected with pIRES2- -EGFP or pIRES2- var-EGFP
(Fig. 7 A, graph refers to   [red] and  var [black]). Reactiv-
ity with mAb 15–1, which is specific for the IgE-binding
epitope (5, 23), was monitored in a population gated for
EGFP expression as a marker for successful transfection with
  or  var. Although we observed surface expression of IgE-
binding epitopes in cells transfected with pIRES2- -EGFP,
this surface marker was significantly down-regulated in cells
transfected with pIRES2- var-EGFP (Fig. 7 A, representa-
tive experiment). Transfections in CHO   cells yield the
same results (unpublished data). Our experiments confirm
that  var impairs formation of surface expressed IgE-binding
epitopes in vivo and functions in a dominant way when co-
expressed with   in CHO   cells (13).
 var induces accumulation of   sig in vivo
We next explored the mechanism by which  var might inter-
fere with the generation of IgE-binding epitopes. For this
purpose we generated a COOH-terminally HA-tagged ver-
sion of Kb-  ( HA) because the commonly used anti-  re-
agents failed to detect the 30-kD   protein backbone and
yielded poor results when used for immunoprecipitation in
pulse-chase experiments. Anti-HA immunoprecipitation fol-
lowed by anti-HA immunoblotting on 293 cells transiently
transfected with  HA confirmed that  HA is properly N-gly-
cosylated in the absence of   or   subunits (Fig. 7 B, lane 1;
31). The presence of unglycosylated   protein backbone was
specific for the presence of  var (Fig. 7 B, lane 3).
Metabolic labeling experiments were then performed to
shown that the   protein that accumulates in the presence
of  var is indeed   sig. Anti-HA immunoprecipitations fol-
lowed by EndoH digestion were performed in cells transiently
transfected with  HA var  (Fig. 7 C). These experiments
shown that most  HA is transformed into its fully N-glycosy-
lated modification irrespectively of the presence of the  var
subunits. Comparing its characteristic with EndoH-treated
protein, the remaining  HA protein can be identified as   sig
(Fig. 7 C). We could thus confirm by both immunoblotting
and by pulse labeling that  var allows accumulation of   sig.
For more extended studies of the intracellular fate of  ,
NH2-terminal EGFP fusion proteins of   or  var (GFP-  or
GFP- var) were generated. The fusion adds the expected 28
kD to the molecular mass but otherwise does not interfere
with the molecular characteristics of either protein (refer-
ence 13; Fig. 8 A; and unpublished data). Pulse-chase analy-
sis of GFP-  or GFP- var demonstrates that both proteins
are stabilized when inhibitors of the proteasome are present
(Fig. 8 A). Pretreatment of cells with proteasome inhibitor
ZL3VS (5  m, 1 h; reference 32) and its presence through-
out the pulse chase stabilize   as well as  var throughout the
chase (Fig. 8 A). We infer that the   subunits are subject to
proteasomal proteolysis with  var more susceptible to protea-
somal degradation. GFP-  and GFP- var should be informa-
tive reagents for the analysis of the fate of the   subunit at
the single cell level.
To this end, CHO   cells were transiently transfected
with GFP-  and GFP- var and analyzed by epifluorescence.
Cells were treated with ZL3VS to inhibit proteasomal degra-
dation for 2 h, fixed, and stained with mAb 15–1 to visualize
the IgE-binding form of   as previously described (23, 33).
Staining with the anti-  polyclonal serum was performed to
Figure 6. Cotranslational formation of tetrameric Fc RI complexes. 
(A)  , ,  , or  , var,   mRNAs were simultaneously translated into CC 
microsomes. Microsomal pellets were solibilized in 1% Brij96 lysis buffer 
and immunoprecipitations with anti-  or control serum were performed. 
Stable     as well as   var  complexes were retrieved by anti- . (B)  var 
induces the accumulation of   sig.   var  mRNAs were cotranslated and 
direct loads of in vitro translations were compared with anti-  immuno-
precipitates. All translated proteins with a prominent band of  33 kD are 
present in direct loads of CC mircosomes translated with   var  . Anti-  
immunoprecipitation shows an overrepresentation of   sig when com-
pared with translations of   alone. Proteins were precipitated from 1% 
Brij96 lysates of in vitro translations from CC pellets and analyzed by 
12.5% SDS-PAGE under reducing conditions. Representative experiments 
(n   3).JEM VOL. 201, January 17, 2005 273
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visualize all forms of  . CHO   transfected with GFP-  are
positive for both mAb 15–1 and the anti-  serum (Fig. 8 B).
In contrast, CHO   transfected with GFP- var do not stain
with mAb 15–1 but still remain positive with the anti-  se-
rum (Fig. 8 B). Experiments performed with CHO    cells
show identical results (unpublished data). It is important to
note that inclusion of the proteasome inhibitor did not res-
cue the expression of IgE-binding epitopes. In agreement
with our in vitro translation results, this experiment demon-
strates that expression of GFP- var interferes with proper
folding and the formation of IgE-binding epitopes on the  
subunit. Cells transfected with GFP- var still express readily
detectable unfolded   chain, suggestive of the mechanism
by which  var and GFP- var down-regulate IgE-binding
epitopes. In experiments without inhibition of proteasomal
activity, GFP- var is more difficult to detect but can still be
visualized. Such cells also contain unfolded   chain but are
devoid of IgE-binding epitopes, as visualized by staining
with anti-  serum or 15–1, respectively (unpublished data).
Additionally we performed a set of pulse-chase experi-
ments to confirm on the cellular level, that Fc RI  is indeed
not targeted to proteasomal degradation by  var. Fc RI HA
was transiently transfected into 293 cells in the presence of
   or  var  cDNA (Fig. 8 C). Immunoprecipitations were
performed with anti-HA in 1% NP-40 lysis buffer to assure
access to the total cellular pool of Fc RI . No enhanced
degradation of any form of Fc RI  was observed in cells
transfected with   var . In correlation with the results pre-
sented earlier in this study, the only significant difference was
the persistence of   sig in the presence of  var. The slight and
progressive decrease in the molecular weight of  Nglyc ob-
served in all conditions is attributable to mannose trimming
(32, 34). We failed to detect  mod in this experimental set-
ting. Next we compared Fc RI  protein levels in   var 
transfectants in the presence and absence of proteasome in-
hibitors (Fig. 8 D). Although proteasomal inhibition stabi-
lizes  var (reference 13; Fig. 8 A; and unpublished data), we
do not detect alterations in the amount or expression pattern
of Fc RI . Because inclusion of proteasome inhibitor and
consequent stabilization of  var do not change the fate of
Fc RI    is not targeted to proteasomal degradation. We
consider it unlikely that the short half-life of  var is of func-
tional importance for this mechanism.
DISCUSSION
Allergen- and IgE-dependent cross-linking of Fc RI is re-
sponsible for the immediate as well as the chronic inflamma-
tory responses observed in atopic patients (5, 6). Surface ex-
pression of Fc RI critically determines the sensitivity to an
allergic stimulus and is therefore pivotal for the ensuing clin-
lates specifically in the presence of  var. (E)  var induces the accumulation of 
  sig. Metabolic labeling of cells transiently transfected with  HA,   and   
followed by anti-HA immunoprecipitations and EndoH digestion. Most  HA is 
rapidly transformed into its fully N-glycosylated modification ( Nglyc). Suscep-
tibility to EndoH treatment defines   sig.
Figure 7. Fc RI var induces the accumulation of   sig in vivo. (A)  var 
down-regulates surface IgE-binding epitopes.   and  var were subcloned into 
a bicistronic vector expressing EGFP to control for equal expression levels 
(pIRES2- -EGFP and pIRES2- var-EGFP). 293 cells were transiently transfected 
and treated with proteasome inhibitor for 2 h. After SDS lysis, immunoblots 
with anti-  serum were preformed to demonstrate the expression of both 
proteins. (B) mAb 15–1 recognizes the IgE-binding epitope of Fc RI . IgE 
binding capacity of CHO   was assessed with biotinylated IgE (black). Prein-
cubation with mAb 15–1 (reactivity shown in blue) inhibits subsequent IgE 
binding (red).  Mean fluorescence is shown on the abscissa. (C) CHO    
were transiently transfected with pIRES2- -EGFP or pIRES2- var-EGFP 
(  (red) and  var(black)). Reactivity of mAb 15–1, which is specific for the IgE-
binding epitope, was monitored on the surface of a cell population gated for 
EGFP-expression as a marker for expression of   and  var. pIRES2- var-EGFP 
specifically down-regulates surface 15–1 reactivity. (D)  var induces accumu-
lation of unglycosylated   protein backbone in vivo. A HA-tagged version of 
Kb-  ( HA) was transiently transfected into 293 cells in the presence of the 
indicated Fc RI subunits. Transfection was followed by anti-HA immunopre-
cipitation and anti-HA immunoblotting.  HA folds properly and becomes 
N-glycosylated ( Nglyc) in the absence of other complex subunits (lane 1). 
Cotransfection of    (lane 4) or  var  (lane 3) induces Golgi-associated glyco-
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ical response. The only defined extracellular regulator of
Fc RI surface expression defined so far is IgE, its natural
ligand (5). With regard to intracellular regulation of receptor
expression, Fc RI  was described as an amplifier for   chain
signaling as well as for receptor surface expression (14, 15).
In contrast,  var has been shown to down-regulate surface
expression of   (13). The mechanistic basis of these regula-
tory events is poorly understood. Glycosylation-mediated
quality control regulates ER export of Fc RI (31). Here we
show the efficiency of ER assembly is controlled by the
Figure 8. Fc RI var induces the accumulation of improperly folded 
Fc RI  in vivo. (A) NH2-terminal EGFP-fusion proteins of   or  var (GFP-  
or GFP- var) were transiently transfected into 293 cells with lipofectamine. 
The fusion adds the expected 28kD to the molecular weight but otherwise 
does not interfere with the molecular characteristics of   or  var. Pulse-
chase analysis: cells were analyzed untreated or pretreated with proteasome 
inhibitor ZL3VS (5  m, 2 h). Anti-GFP immunoprecipitates were obtained 
from 1% NP-40 lysates and analyzed by 12.5% SDS-PAGE under reducing 
conditions. Inhibition of the proteasome stabilizes GFP- var. (B) CHO   
were transiently transfected with GFP-  and GFP- var and analyzed by 
epifluorescence. Cells were treated with ZL3VS for 2 h, fixed and stained 
with mAb 15–1 to visualize IgE-binding epitopes. Staining with the anti-  
polyclonal serum was performed to visualize all forms of  . Transfection 
with the GFP-  does not influence mAb 15–1 reactivity. Cells transfected 
with GFP- var do not show mAb 15–1 reactivity but still remain positive 
with the anti-  serum indicative for the presence of unfolded   chain. 
Representative experiment (n   4). (C, D) Pulse-chase experiments to con-
firm that Fc RI  not targeted to proteasomal degradation by  var. Fc RI HA 
was transiently transfected into 293 cells in the presence of    or  var  
cDNA. Transfection, immunoprecipitations and analysis were performed as 
described in (A).   sig is stabilized by the presence of  var selectively (C). 
(D) Comparison of Fc RI  protein levels in   var  transfectants in the 
presence and absence of proteasome inhibitors. No alterations in the 
amount or expression pattern of Fc RI  in induced by the inhibitor.JEM VOL. 201, January 17, 2005 275
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presence of the different subunits. We were able to define
the IgE-binding   chain as the core of the receptor that pairs
with the other subunits in a strictly cotranslationally regu-
lated assembly event. These experiments establish ER assem-
bly as a rate-limiting step in the expression of functional sur-
face receptors, with obvious consequences for the onset of
allergic diseases. In addition to the well-described Fc RI iso-
forms, we were also able to demonstrate the existence of
  var  and    complexes, not previously documented.
Protein synthesis and folding in the ER are not always ef-
ficient: improperly folded structures are cleared from the ER
and directed toward degradation (19–21). In addition to the
proper folding of the individual subunits, multimeric recep-
tors must assemble in a concerted fashion. Receptors such as
Fc RI or the TCR assemble in the ER and maintain their
integrity by noncovalent interaction of the various subunits.
Only with all players in place can ER retention signals be
overcome (5, 9). For the TCR this process is well established
and occurs in three consecutive assembly steps (17). Although
Fc RI and TCR share the same principal structure of ligand-
binding and signal-transducing units and can even use the
same   chain for signaling (5), we show that their assembly is
regulated differently. Fc RI complexes form strictly cotrans-
lationally. The presence of   and   clearly favors a conversion
of   into its IgE-binding form when compared with transla-
tion in the presence of   alone. The  var, on the other hand,
slows down this conversion and induces the accumulation of
unglycosylated   with the signal peptide still in place.
Not all Fc RI receptor subunit RNAs are generated in
the same quantities in primary cells. When compared with  ,
  is always underrepresented (5). These observations were
also confirmed at the protein level (11, 23). The demands of
receptor stochiometry make cotranslational assembly of the
receptor a key step that controls expression of functional IgE-
binding epitopes at the cell surface. It may thereby affect the
susceptibility to allergic stimuli in vivo. Receptor   subunits
can still fold properly, but do so at a less efficient rate when
compared with folding in the presence of   and  . Such  
chains lack the necessary partners for complex formation dur-
ing translation and consequently for ER exit. Our finding
thus provides an explanation for the intracellular accumula-
tion of   in cell types that express high levels of  , which in
principle should allow surface expression (5). It is possible that
in such cells, translation of   and   might not occur in syn-
chrony and thus ER exit may be compromised. In addition to
its critical role for Fc RI signaling and ER exit, Fc RI  is a
subunit of Fc  receptors (35). Functional association of
Fc RI  with CD16, Fc RIII, has also been demonstrated
(36, 37). Both Fc receptor types might thus compete for  
and   subunits, which adds an additional level of complexity
and importance to assembly control. Because various Fc  re-
ceptor subtypes and Fc RI are expressed simultaneously in a
variety of cell types (e.g., monocytes, dendritic cells, Langer-
hans cells, mast cells), this event is of physiological impor-
tance. Antigen presenting cells and monocytes of all individu-
als express Fc  receptors. The proper assembly of Fc 
receptors could indirectly control the expression of Fc RI by
depleting the pool of receptor units that are required for
Fc RI ER exit. The functional consequences of  var expres-
sion for cotranslational assembly need to be interpreted care-
fully, in particular with regard to the fact that so far transcripts
of  var were not depicted in absence of the classic   chain.
Improperly assembled Fc RI subunits are subjected to
the ER quality control system and must be directed toward
degradation. Fc RI var is a natural substrate for proteasomal
degradation and is itself rapidly destroyed, irrespective of the
presence of Fc RI’s other subunits (13). Whereas the   sub-
unit is also degraded by the proteasome, we found no evi-
dence for a redirection of   toward proteasomal degradation
by  var (unpublished data). When expressed alone,  Nglyc is a
rather stable protein. It remains to be established whether
primary cells such as Langerhans cells, eosinophils, or mono-
cytes of allergic patients have a mechanism to direct pre-
formed pools of   toward the cell surface. In view of our re-
sults, this possibility appears at present unlikely.
Our study establishes cotranslational assembly of Fc RI as
the first quality control mechanism for the generation of func-
tional IgE-binding Fc RI. The dysregulation of this quality
control process might contribute to the expression of high
Fc RI levels in allergic patients. We show that the ER quality
control system regulates quantities of functional Fc RI. It
thereby controls onset and persistence of allergic reactions and
might thus be a target for therapeutic interventions.
MATERIALS AND METHODS
DNA constructs. The cDNAs encoding Fc RI , Fc RI , Fc RI var,
and Fc RI  were provided by the laboratory of J.-P. Kinet (Laboratory of
Allergy and Immunology, Beth Israel Deaconess Medical Center, Boston,
MA) (13). Signal peptide encoding sequences of   and   were exchanged
for the signal peptide of mouse class I heavy chain H2-Kb (16). All cDNAs
were cloned into pcDNA3.1 under the control of the T7 promotor.   and
 var were also subcloned into pIRES2-EGFP (CLONTECH Laboratories,
Inc.). NH2-terminal EGFP fusion proteins of   and  var were generated in
pEGFP-C1 (CLONTECH Laboratories, Inc.). A COOH-terminal Kb- HA
fusion protein was generated and expressed in pcDNA3.1.
Antibodies and antisera. cIgE (Serotec) and mAb 15–1 recognize the
IgE-binding epitope of   and were used for the detection of properly folded
and N-glycosylated form of the protein (11, 12). Polyclonal rabbit anti- 
recognizes all forms of the protein irrespective of its folding status. Antisera
against  ,  , and   are published and were used as described in the literature
(13).  GFP was generated by immunizing rabbits with the bacterially ex-
pressed GFP and used as previously described (32). HA-tagged proteins
were precipitated with mAb 12CA5 and detected with HRP-conjugated rat
mAb 3F10 (Roche).
Cell lines and transient transfections. 293, CHO    and CHO  
cells were maintained in DMEM as previously described (13, 23). Various
constructs of   and  var were expressed in 293, CHO  , or CHO    cells
by transient transfection, using a liposome-mediated transfection protocol
(5–10  g of DNA, 20  l of lipofectamine, 10 cm dish; Lipofectamine;
GIBCO BRL) as previously described (33). Cells were analyzed between 24
and 48 h after transfection.
In vitro transcription and translation. Both methods were essentially
performed as previously described (16, 25, 26). In vitro transcriptions were
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into pcDNA3.1. After linearization, T7 polymerase was used for in vitro
transcription (Promega). RNA was caped as previously described and stored
as alcohol precipitates at  80 C. Before translation, RNA was decaped.
Optimal amount of the individual RNAs was determined empirically for
each individual receptor subunit and each stock of RNA. RNAs were
stored as alcohol precipitates at  80 C. The optimal reaction time of the in
vitro translation was determined empirically as 1 h. Reticulocyte lysate was
purchased from Promega. Microsomes were prepared from various cell lines
as previously described and pelleted after in vitro translations for further
analysis as previously described (26). Complex precipitations of Fc RI were
performed in 1% Brij 96 lysates as previously described (11).
Metabolic labeling of cell, pulse-chase experiments, immunoprecipita-
tion, enzymatic digestion, and immunoblotting 293 cells were detached,
followed by starvation in methionine-/cysteine-free DME for 60 min at
37 C. Cells were metabolically labeled with 500  Ci of [35S]methionine/
cysteine (1,200 Ci/mM; NEN)/ml at 37 C for the times indicated. Pulse-
chase experiments, cell lysis, and immunoprecipitations were performed as
previously described (33). 1% Brij96 lysis buffer was used to maintain the
integrity of Fc RI complexes as previously described (11). The immuno-
precipitates were analyzed by SDS-PAGE followed by fluorography (38).
Endo H (New England Biolabs, Inc.) digestions was performed as described
by the manufacture.  HA immunoblots were performed with SDS lysates
under nonreducing conditions (23).
Flow cytometry analysis. Quantitative flow cytometry analysis of cells
expressing constructs in pIRES2-EGFP in living cells was performed by
FACS® (FACS®Calibur; BD, Mountain View, CA) supported by
CellQuest software (BD). IgE-binding epitopes of Fc RI  were stained
with mAb15-1 or biotinylated IgE as previously described (13, 23, 28–30).
Immunostaining and epifluorescence microscopy. Immunofluores-
cence experiments were performed essentially as previously described (39)
with minor modifications as follows. Cells were allowed to attach to slides
overnight before inhibitor incubation (ZL3VS; reference 40; 4 h 10  M fi-
nal from a DMSO stock). DMSO was used as solvent control. After fixation
with 3.7% paraformaldehyde for 20 min at room temperature immunohis-
tochemistry was performed in a 0.5% saponin/3% BSA/PBS solution. mAbs
15–1 was used to define   chains that exhibit properly folded IgE-binding
epitopes (13, 23). Polyclonal anti-  serum was used to show all forms of  
irrespective of their folding or glycosylation status (13). Anti-mouse Alexa
Fluor 568 (Molecular Probes) and anti-rabbit Alexa Fluor 568 (Molecular
Probes) were used as the fluorescent probe. Further analysis was performed
with a Bio-Rad epifluorescence microscope as previously described (39).
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